
Cryopreserved Mouse Hepatocytes from PRIMACYT.
Primary hepatocytes are perfect models for in vitro metabolism and toxicity studies. They are essential before clinical in vivo assessments and for bioaccumulation and clearance studies,
The liver fulfills many vital processes in the body for energy metabolisms, such as glycolysis, gluconeogenesis, lipid, and amino acid metabolisms.
Under physiological and pathophysiological conditions, the liver is responsible for the maintenance of the blood sugar level and the synthesis of plasma proteins, ammonia detoxification (ureagenesis), and drug metabolism.
NPCs play a pivotal role during inflammatory response and fibrosis, interacting with hepatocytes and thereby complementing the liver-specific functions. Non-parenchymal liver cells, NPCs, include Kupffer cells, endothelial cells, and fat-storing cells, such as Ito cells, hepatic stellate cells).
Primary hepatocytes are perfect models for in vitro metabolism and toxicity studies. They are essential before clinical in vivo assessments and for bioaccumulation and clearance studies,
The liver fulfills many vital processes in the body for energy metabolisms, such as glycolysis, gluconeogenesis, lipid, and amino acid metabolisms.
Under physiological and pathophysiological conditions, the liver is responsible for the maintenance of the blood sugar level and the synthesis of plasma proteins, ammonia detoxification (ureagenesis), and drug metabolism.
NPCs play a pivotal role during inflammatory response and fibrosis, interacting with hepatocytes and thereby complementing the liver-specific functions. Non-parenchymal liver cells, NPCs, include Kupffer cells, endothelial cells, and fat-storing cells, such as Ito cells, hepatic stellate cells).
Product Code MHCP-I. CD-1 Mouse Hepatocytes Cryopreserved Plateable for Induction Studies - Lot and Order Information
- Inventory: Number of vials available as of date of last update. Availability of vials may have changed since that date by interim orders.
- Viability: Denotes post thaw results using the standard thawing protocol.
- To print lot information, please select print icon at the end of this list.
2022-01-11
Lot / Gender |
Inventory (Number of vials) |
Viability (%) |
Recovery (Number of viable cells/vial) |
Total number of cells available |
CYP1A1/1A2 induction x-fold |
EUR / Vial |
---|---|---|---|---|---|---|
MHCP-I |
2 |
80.0 |
> 2 Mio |
> 4 Mio |
4.3 |
605.00 |
MHCP-I |
3 |
76,7 |
> 2 Mio |
> 6 Mio |
4.2 |
605.00 |
MHCP-I |
6 |
87.5 |
> 2 Mio |
> 12Mio |
2.2 |
605.00 |
MHCP-I |
5 |
77.3 |
> 2 Mio |
> 10Mio |
2-6 |
605.00 |
Product Code MHCP. CD1-Mouse Hepatocytes Cryopreserved Plateable - Lot and Order Information.
- Inventory: Number of vials available as of date of last update. Availability of vials may have changed since that date by interim orders.
- Viability: Denotes post thaw results using the standard thawing protocol.
- To print lot information, please select print icon at the end of this list.
2022-01-11
Lot / Gender |
Inventory (Number of vials) |
Viability (%) |
Recovery (Number of viable cells/vial) |
Total number of cells available |
CYP1A1/1A2 induction x-fold |
EUR / Vial |
---|---|---|---|---|---|---|
MH191114-pool Male |
10 |
80.7 +/- 2.8 |
> 2 Mio |
>20 Mio |
n/a |
565.00 |
MH210623 |
7 |
90.8 |
< 2 Mio |
>7 Mio |
n/a |
280.00 |
MH210811 |
5 |
89.6 |
> 2 Mio |
>10 Mio |
n/a |
565.00 |
MH2109203 |
4 |
79.7 |
> 2 Mio |
> 4 Mio |
n/a |
280.00 |
MH211011-1 |
9 |
88.1 |
> 2 Mio |
> 18 Mio |
n/a |
565.00 |
MH211102 |
5 |
94.3 |
> 2 Mio |
> 10 Mio |
n/a |
565.00 |
MH211111 |
6 |
70.2 |
< 2 Mio |
> 6 Mio |
n/a |
280.00 |
MH211202-1 |
37 |
79.9 |
> 2 Mio |
> 74 Mio |
n/a |
565.00 |
Product Code MHCS. CD1 Mouse Hepatocytes for use in Suspension - Lot and Order Information.
- Inventory: Number of vials available as of date of last update. Availability of vials may have changed since that date by interim orders.
- Viability: Denotes post thaw results using the standard thawing protocol.
- To print lot information, please select print icon at the end of this list.
2022-01-11
Lot / Gender |
Inventory (Number of vials) |
Viability (%) |
Recovery (Number of viable cells/vial) |
Total number of cells available |
CYP1A1/1A2 induction x-fold |
EUR / Vial |
---|---|---|---|---|---|---|
MH210330-2 |
6 |
83.9 +/- 1.0 |
> 2 Mio |
>12 Mio |
n/a |
320.00 |
MH210715 |
12 |
88.0 +/- 0.3 |
< 2 Mio |
>12 Mio |
n/a |
320.00 |